Page last updated: 2024-10-24

positive regulation of bleb assembly

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of bleb assembly. [GO_REF:0000058, GOC:als, GOC:TermGenie, PMID:25651887]

Positive regulation of bleb assembly is a complex process involving the coordinated action of multiple cellular components. Blebs are protrusions of the plasma membrane that can occur in a variety of cellular contexts, including cell migration, wound healing, and apoptosis. They are typically characterized by a spherical shape and a lack of underlying cytoskeletal support.

The formation of blebs is driven by the localized increase in pressure within the cell. This pressure can be generated by a variety of mechanisms, including the accumulation of intracellular fluid, the activation of ion channels, and the disruption of the cytoskeleton.

The positive regulation of bleb assembly involves the activation of signaling pathways that promote the formation of blebs. One important pathway involves the Rho family of small GTPases, particularly RhoA. Activation of RhoA leads to the assembly of actomyosin filaments, which can contribute to the generation of pressure within the cell.

Another important signaling pathway involves the phosphoinositide 3-kinase (PI3K) pathway. Activation of PI3K leads to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3), which can recruit and activate a variety of downstream signaling molecules, including Akt and Rac1. Akt can promote cell survival and growth, while Rac1 can promote actin polymerization and membrane ruffling.

The coordinated action of these signaling pathways ultimately leads to the formation of blebs. The precise mechanisms by which blebs are formed are still being investigated, but it is clear that they involve a complex interplay between the cytoskeleton, the plasma membrane, and various signaling molecules.

In addition to these molecular pathways, a number of environmental factors can also influence bleb formation. For example, mechanical stress, such as that experienced by cells during migration or wound healing, can promote bleb formation. Similarly, changes in cell volume, such as those that occur during apoptosis, can also trigger bleb formation.

Overall, positive regulation of bleb assembly is a dynamic process that is influenced by a variety of factors, both intracellular and extracellular. Further research is needed to fully understand the mechanisms involved in this process.'
"

Proteins (1)

ProteinDefinitionTaxonomy
P2X purinoceptor 7A P2X purinoceptor 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99572]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
oxatomideoxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.

oxatomide: structure; an anti-allergic & an anti-asthmatic
benzimidazoles;
diarylmethane;
N-alkylpiperazine
anti-allergic agent;
anti-inflammatory agent;
geroprotector;
H1-receptor antagonist;
serotonergic antagonist
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
arenesulfonic acid;
azobenzenes;
methylpyridines;
monohydroxypyridine;
organic phosphate;
pyridinecarbaldehyde
purinergic receptor P2X antagonist
suraminsuramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
naphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
alpha,beta-methyleneadenosine 5'-triphosphatealpha,beta-methyleneadenosine 5'-triphosphate: do not confuse with beta,gamma-methylene ATP; RN given refers to parent cpdnucleoside triphosphate analogue
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
8-azidoadenosine 5'-triphosphate
6-thioinosine-5'-triphosphateorganic molecule
mrs2159MRS2159: an antagonist of both P2X1 and P2X7 receptors
imd 0354N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide: a cardioprotective agent that inhibits IkappaB kinase beta (IKKbeta); structure in first sourcebenzamides
kn 62KN 62: inhibitor of Ca/calmodulin-dependent protein kinase IIpiperazines
az 11645373AZ 11645373: InChIKey: VQEHBLGYANQWEA-UHFFFAOYSA-N
az10606120AZ10606120: a P2X7 receptor antagonist
ce 224,535CE 224,535: structure in first source
a-438079
af 3535-(5-iodo-2-isopropyl-4-methoxyphenoxy)pyrimidine-2,4-diamine: a P2X3 and P2X2/3 receptor antagonist; structure in first source
gsk1482160
a-839977A-839977: a selective P2X7 receptor antagonist, analgesic; structure in first source
jnj-47965567JNJ-47965567: a P2X7 purinergic receptor antagonist; structure in first source
mk-8742elbasvir : A complex organic heterotetracyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with grazoprevir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.

elbasvir: inhibits NS5A protein of hepatitis C virus
carbamate ester;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heterotetracyclic compound;
ring assembly
antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor;
hepatoprotective agent